US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

39.37

0.0000

Volume:196

Turnover:7.68K

Market Cap:7.87M

PE:- -

High:39.37

Open:39.37

Low:39.37

Close:39.37

52wk High:43.01

52wk Low:25.42

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.30

T/O Rate:0.10%

Dividend:0.32

Dividend Rate:0.81%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND)

Grail announces FDA advisory committee meeting to review Galleri test PMA

Praxis Precision Med is Maintained at Equal-Weight by Wells Fargo

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)

Praxis Precision price target raised to $514 from $400 at Baird

Praxis Precision Medicines, Inc. : Deutsche Bank Raises Target Price to $475 from $374

THOMSON REUTERS

Scholar Rock Holding Corporation : Bmo Raises Target Price to $76 from $70

THOMSON REUTERS

Hong Kong Stocks Update | INSILICO Surges Over 9% as ISM8969/HT-001 Receives NMPA Clinical Trial Approval for Parkinson's Disease Treatment

Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26

Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million

Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million

THOMSON REUTERS

Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029

THOMSON REUTERS

Xenon Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS

The Race to Come up with the Next Big Sleep Drug

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Privia Health Group (PRVA) and Praxis Precision Medicines (PRAX)

Praxis Precision Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Scholar Rock Holding Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IBRN/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":39.3744,"timestamp":1788531942552,"preClose":39.3744,"halted":0,"volume":196,"delay":0,"changeRate":0,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":0,"latestTime":"09-04 10:30:30 EDT","open":39.3744,"high":39.3744,"low":39.3744,"amount":7680.8578,"amplitude":0,"askPrice":39.16,"askSize":300,"bidPrice":38.88,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.3744,"sharesOutstanding":150000,"nav":39.408165,"aum":7881633,"dividendRate":0.008114,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.38,"preClose":39.3744,"latestTime":"16:10 EDT","volume":6,"amount":235.9776,"timestamp":1788466204933,"change":0.0056,"changeRate":0.000142,"amplitude":0},"volumeRatio":0.302495,"impliedVol":0.0707,"impliedVolPercentile":0.246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.302495,"shares":200000,"dividePrice":0.3195,"high":39.3744,"amplitude":0,"preClose":39.3744,"low":39.3744,"week52Low":25.4196,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":39.3744,"eps":0,"divideRate":0.008114,"volume":196,"delay":0,"ttmEps":0,"open":39.3744,"prevYearClose":32.3193,"prevWeekClose":39.2301,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":39.2301,"twentyDayClose":38.8576,"sixtyDayClose":33.9605},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657628511","title":"Analysts Offer Insights on Healthcare Companies: Progyny (PGNY), Scholar Rock Holding (SRRK) and Ascendis Pharma (ASND)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657628511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657628511?lang=en_us&edition=fundamental","pubTime":"2026-08-08 01:10","pubTimestamp":1786122610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Progyny (PGNY), Scholar Rock Holding (SRRK) and Asce...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-progyny-pgny-scholar-rock-holding-srrk-and-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-progyny-pgny-scholar-rock-holding-srrk-and-ascendis-pharma-asnd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["THNR","LU0320765992.SGD","LU0109394709.USD","BK4588","PGNY","MEDI","LU0029874061.USD","LU1878469433.USD","SRRK","BK4154","LU0889565916.HKD","BK4137","HCSG","BK4581","XLV","BK4139","LABU","ASND","IBRN","BK4585","LU0128526141.USD","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642727","title":"Grail announces FDA advisory committee meeting to review Galleri test PMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642727","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642727?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:10","pubTimestamp":1786115445,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-announces-fda-advisory-committee-meeting-to-review-galleri-test-pma-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","PBE","BK4139","BK4588","BBP","FBT","BK4129","BK4585","GRAL","SBIO","XBIX","PMA","LABU","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641228","title":"Praxis Precision Med is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641228","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641228?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:07","pubTimestamp":1786111620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRAX/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0162691827.USD","LU0211327993.USD","LU2461242641.AUD","LU0251142724.SGD","LU0868494708.USD","IE0002141913.USD","IE0002270589.USD","LU1506573853.SGD","LU1201861249.SGD","LU2361044949.HKD","IE00B19Z3B42.SGD","LU1894683264.USD","PGF","KBWB","LU0417517546.SGD","LU0149725797.USD","LU2236285917.USD","LU0310800965.SGD","BK4207","LU0320765489.SGD","LU0971096721.USD","IE00B19Z3581.USD","LU0742534661.SGD","BK4559","LU0889565916.HKD","LU0128525689.USD","BK4504","LU1074936037.SGD","LU0256863811.USD","LU0868494617.USD","LU0072461881.USD","LU0320765992.SGD","IE0009355771.USD","PRAX","LU1280957306.USD","LU1814569148.SGD","LU0048573561.USD","LU1267930227.SGD","LU0211328371.USD","BK4582","IBRN","FTXO","IE00BJT1NW94.SGD","IYF","LU0640476718.USD","BK4585","IE00BFTCPJ56.SGD","TFNS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657645754","title":"Analysts Offer Insights on Healthcare Companies: Viatris (VTRS), Immunocore Holdings (IMCR) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657645754","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657645754?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:40","pubTimestamp":1786106428,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viatris (VTRS), Immunocore Holdings (IMCR) and Pra...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-immunocore-holdings-imcr-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-viatris-vtrs-immunocore-holdings-imcr-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B2B36J28.USD","BK4588","LU0128526141.USD","LU0109394709.USD","IBRN","LU0029874061.USD","BK4139","LU1839511570.USD","LU0320765992.SGD","LU0889565916.HKD","XLV","HCSG","IMCR","IE00BJJMRZ35.SGD","BK4583","PRAX","BK4137","XBI","VTRS","LU2087621335.USD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4007","BK4505","BK4581","LABU","IE0002141913.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657643664","title":"Praxis Precision price target raised to $514 from $400 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2657643664","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657643664?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:01","pubTimestamp":1786104075,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Praxis Precision (PRAX) to $514 from $400 and keeps an Outperform rating on the shares. The firm updated it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-514-from-400-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/praxis-precision-price-target-raised-to-514-from-400-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IBRN","IE0002141913.USD","LU0320765992.SGD","BK4139","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","PRAX","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648808","title":"Praxis Precision Medicines, Inc. : Deutsche Bank Raises Target Price to $475 from $374","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648808?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:26","pubTimestamp":1786101999,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN44419L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002141913.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0320765992.SGD","PRAX","BK4139","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IBRN","LU0889565916.HKD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657610982","title":"Scholar Rock Holding Corporation : Bmo Raises Target Price to $76 from $70","url":"https://stock-news.laohu8.com/highlight/detail?id=2657610982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657610982?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:08","pubTimestamp":1786100892,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nFWN444123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","SRRK","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136673857","title":"Hong Kong Stocks Update | INSILICO Surges Over 9% as ISM8969/HT-001 Receives NMPA Clinical Trial Approval for Parkinson's Disease Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1136673857","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136673857?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:10","pubTimestamp":1786083017,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) surged more than 9%, trading up 8.1% at HK$44.3 as of the latest update, with a turnover of HK$541 million.According to recent news from Insilico's official WeChat account,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","IBBJ","IBRN","PSYK","VXUS","BK1141","03696","BK1612","BK4181","BMED","BK4218","MDTX","BK4588","01611","IBBQ","HT","BK4585","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657080663","title":"Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657080663","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657080663?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:01","pubTimestamp":1786050101,"startTime":"0","endTime":"0","summary":"Xenon Pharmaceuticals Inc. reports results for the quarter ended June 30 - Earnings SummaryXenon Pharmaceuticals Inc.XENE.OQreported a quarterly adjusted loss of $1.11 per share for the quarter ended ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4433E4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","XENE","BK4139","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650957","title":"Definium Therapeutics Q2 Net Loss Widens on Higher Warrant Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650957","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650957?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:17","pubTimestamp":1786047436,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Q2 net loss widens on higher warrant costsOverviewUS biopharma firm's Q2 net loss widens, driven by higher warrant liabilities and expensesCompany raised $805 mln in public offer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IE0009355771.USD","IBRN","LU0320765992.SGD","PRAX","IE0002141913.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4139","VTVT","IE00BFTCPJ56.SGD","LU0889565916.HKD","DTIL","DFTX","IE00BJT1NW94.SGD","BK4007","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657650887","title":"Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2657650887","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657650887?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:14","pubTimestamp":1786047240,"startTime":"0","endTime":"0","summary":"Canada's Xenon Pharma Q2 net loss widens on higher expensesOverviewCanada neuroscience drug developer's Q2 net loss widened and missed analyst expectationsHigher R&D and administrative costs drove the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431DZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IMRX","BK4539","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4007","PSIL","LU0889565916.HKD","IE0009355771.USD","LU2065171311.SGD","LU2324357040.USD","SBIO","LU0154245673.USD","BK4563","GHRS","LU2065170008.USD","LU0109394709.USD","LU0823416689.USD","IBRN","LU2065169927.USD","LU0154245756.USD","NBIX","BK4139","LU0320765992.SGD","LU2065171402.SGD","XENE","PRAX","IE00B2B36J28.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571056","title":"Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571056","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571056?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:07","pubTimestamp":1786046831,"startTime":"0","endTime":"0","summary":"Xenon net loss widens 30.7% to $110.74 million in Q2 FY26Xenon posted a Q2 net loss of USD 110.7 million, widening from USD 84.7 million a year earlier.R&D costs rose to USD 99.2 million from USD 75 m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDLbgCR29:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","IBRN","LU2095319765.USD","BK4139","BK4112","IE00BGHQF748.EUR","NDAQ","SG9999014013.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4585","LU2210149790.SGD","BK4588","IE00BN0W2W23.USD","XENE","BCDF","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BN0W2V16.EUR","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657365271","title":"Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657365271","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657365271?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:02","pubTimestamp":1786046521,"startTime":"0","endTime":"0","summary":"BRIEF-Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 MillionAug 06 (Reuters) - Xenon Pharmaceuticals Q2 income from operations USD -123.155 million.Q2 operating expenses USD 123.155 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SBIO","XENE","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652480","title":"Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652480?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SBIO","XENE","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521606","title":"Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521606?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nPLXHL9M8F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","XENE","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657465223","title":"Xenon Reports Q2 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657465223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657465223?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:01","pubTimestamp":1786046461,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nTUA4YCGCT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XENE","IBRN","BK4139","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651052","title":"The Race to Come up with the Next Big Sleep Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651052","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651052?lang=en_us&edition=fundamental","pubTime":"2026-08-07 02:30","pubTimestamp":1786041000,"startTime":"0","endTime":"0","summary":"Narcolepsy isn't easy to treat. Existing drugs manage patients' symptoms -- notably excessive daytime sleepiness and difficulty sleeping at night -- rather than the cause. Yet a new type of drug is em","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBT","AGNG","LU2213496289.HKD","LU2602419157.SGD","LU2471134879.HKD","LU0964807845.USD","LU0354030511.USD","THNR","SG9999013999.USD","IE00BKDWB100.SGD","IXJ","LU1979441026.SGD","LU1291159041.SGD","LU1712237335.SGD","LU2360106947.USD","IE00BJLML261.HKD","LU0466842654.USD","BK4588","LU2237443549.SGD","LU2168564222.USD","LU0323591593.USD","SG9999014906.USD","LU2089284900.SGD","LU1093756168.USD","LU1551013425.SGD","LU0820562030.AUD","LU2168564495.EUR","LU0238689110.USD","LU0320765059.SGD","IE0004445015.USD","PJP","LU1804176565.USD","IE00BJJMRY28.SGD","LU2111349929.HKD","LU0203201768.USD","IE0005OL40V9.USD","LU2746668461.USD","LLY","LU0058720904.USD","LU2471134796.USD","LU2324357040.USD","LU0672654240.SGD","IE00BFTCPJ56.SGD","IE00BK4W5M84.HKD","MHIP","LU0353189763.USD","LU0456855351.SGD","LU1127390331.HKD","LU0006306889.USD","LU1267930730.SGD","LU2237438978.USD","LU0174119429.USD","LU0823434740.USD","IE00BJJMRZ35.SGD","LLYX","BK4534","LU2168564065.EUR","IBRN","LU2552382215.SGD","LU2461242641.AUD","LU0122379950.USD","LU1629891620.HKD","IYH","SG9999014914.USD","LU2468319806.SGD","LU1868837136.USD","LU0114720955.EUR","IHE","LU1280957306.USD","LU1069344957.HKD","SGXZ57979304.SGD","LU0345770993.USD","BK4533","LU2087625088.SGD","IE00BWXC8680.SGD","SG9999015945.SGD","LU0385154629.USD","VHT","SG9999001176.USD","LU0683600562.USD","LU1064131342.USD","LU0471298777.SGD","LU0158827781.USD","LU2750360997.AUD","MEDI","LU0354030438.USD","IE00B2B36J28.USD","ALKS","SGXZ99366536.SGD","LU0943347566.SGD","LU2471134952.CNY","ELIS","LU0289739699.SGD","LU0708995401.HKD","IE00BK4W5L77.USD","LU2750360641.GBP","SG9999014880.SGD","LU0820561818.USD","LU2023250504.SGD","HRTS","PSCH","LU2756315318.SGD","SG9999001176.SGD","LU0109394709.USD","LU2168563687.JPY","LU0320765992.SGD","ILDR","MEDX","LU1868836914.USD","SG9999018865.SGD","LU0158827948.USD","LU1868836757.USD","LU0882574055.USD","GB00BDT5M118.USD","LU1023059063.AUD","LU0225283273.USD","LU0882574139.USD","LU0198837287.USD","LU2271345857.HKD","SG9999015952.SGD","ELIL","LLII","IE00BFSS7M15.SGD","IE0004445239.USD","IE00BJJMRX11.SGD","LU0094547139.USD","LU0210536198.USD","LU0417517546.SGD","LU0061475181.USD","LU0234572021.USD","LU1145028129.USD","LU1988902786.USD","LU2028103732.USD","LU2491050154.USD","FHLC","IE00BKPKM429.USD","LU0787776722.HKD","LU2552382132.HKD","OZEM","CANC","LU0316494557.USD","LU0820561909.HKD","LU1232071149.USD","IE00BFSS8Q28.SGD","LU1366192091.USD","LU1917777945.USD","LU1974910355.USD","LU2462591350.SGD","LU2746668974.SGD","LU2491050071.SGD","IE00B4R5TH58.HKD","BK4581","LU2108987350.USD","CURE","FTXH","LU0203202063.USD","LU2089283258.USD","LU2168564149.EUR","LU2237443978.SGD","TRUH","LU0889565916.HKD","IE00B7KXQ091.USD","LU1061106388.HKD","LU0689472784.USD","IE00BJT1NW94.SGD","LU0640476718.USD","LU1623119135.USD","LU0823434583.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU2023250330.USD","LU2237443465.HKD","LU1868836591.USD","LU2896262040.SGD","IE0009355771.USD","WDNA","LU2237443895.HKD","IE00B775H168.HKD","LU1548497426.USD","BK4007","LU0256863811.USD","LU2106854487.HKD","IE0001KFT4U8.USD","LU0096364046.USD","LU2264538146.SGD","LU2361045086.USD","LU0823416689.USD","JDOC","SG9999014898.SGD","LU2462157665.USD","XLV","LU2756315664.SGD","TMED","LU0079474960.USD","LU0266013472.USD","IE00B1XK9C88.USD","IE00B4JS1V06.HKD","LU1868837300.USD","LU2063271972.USD","LU0432979614.USD","LU2023251221.USD","LU0133085943.USD","LU1093756325.SGD","LU1720051017.SGD","LU2361044865.SGD","LU1983299246.USD","LU2112291526.USD","SGXZ81514606.USD","LU2089984988.USD","BK4585","LLYZ","LU1551013342.USD","LU2417539215.USD","IE0002141913.USD","LU2357305700.SGD","LU0786609619.USD","SG9999018857.SGD","LU0256863902.USD","LU0109391861.USD","LU0345770308.USD","LU1057294990.SGD","IE00BN29S564.USD","LU2237443382.USD","LU1323610961.USD","BK4139","LU2237443622.USD","SG9999017495.SGD","PPH","LU2361044949.HKD","LU2491049909.HKD","LU0106261372.USD","TAK","LU1035775433.USD","LU2265009873.SGD","LU2456880835.USD","SGXZ51526630.SGD","GDOC","SG9999015986.USD","LU1814569148.SGD","BK4599","RXL","LU2236285917.USD","PSIL","LU2552382058.USD","LU0097036916.USD","IE00B1BXHZ80.USD","LU2211815571.USD","LU0471298694.HKD","BK4516","SG9999015978.USD","LU2471134523.USD","LU0353189680.USD","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657651400","title":"Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Privia Health Group (PRVA) and Praxis Precision Medicines (PRAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657651400","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657651400?lang=en_us&edition=fundamental","pubTime":"2026-08-07 01:50","pubTimestamp":1786038610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tenaya Therapeutics (TNYA), Privia Health Group (PRV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-privia-health-group-prva-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-tenaya-therapeutics-tnya-privia-health-group-prva-and-praxis-precision-medicines-prax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","IE00B2B36J28.USD","BK4137","XLV","PRAX","IE00BJJMRZ35.SGD","BK4581","BK4139","TNYA","LU0029874061.USD","BK4196","IE0009355771.USD","IBRN","PRVA","LU0889565916.HKD","IE00B4R5TH58.HKD","LU0128526141.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4588","BK4539","XBI","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","HCSG","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657163708","title":"Praxis Precision Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657163708","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657163708?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:07","pubTimestamp":1786025274,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines, Inc. reports results for the quarter ended June 30 - Earnings SummaryPraxis Precision Medicines, Inc.PRAX.OQreported a quarterly adjusted loss of $2.87 per share for the qu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N44326M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0002141913.USD","LU0109394709.USD","LU0320765992.SGD","IBRN","IE00B4R5TH58.HKD","PRAX","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657321716","title":"Scholar Rock Holding Corporation Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657321716","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657321716?lang=en_us&edition=fundamental","pubTime":"2026-08-06 21:31","pubTimestamp":1786023115,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding Corporation reports results for the quarter ended June 30 - Earnings SummaryScholar Rock Holding CorporationSRRK.OQreported a quarterly adjusted loss of 84 cents per share for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL8N4431VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","THNR","IBRN","SRRK"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}